FLGT · Fulgent Genetics, Inc. · Webcasts, Transcripts & Audio
$24.66
-0.19 (-0.76%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$688.98M
Shares
27.94M
Volume · Nov 13
262.12K
Avg daily vol (3M)
323.92K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fulgent Genetics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Fulgent Genetics, Inc. (FLGT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
Fulgent Genetics, Inc. (FLGT) Q3 2026 Earnings Call Transcript
Positive tone
Laboratory services revenue
Margins and operating expenses
Billing and revenue-cycle management transition
Revenue
$90.41M
▲ 7.5% YoY Gross margin
35.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-30
Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call Transcript
Cautious tone
Revised revenue and EPS guidance
M&A integration
Cash position and share repurchases
Revenue
$85.39M
▲ 4.4% YoY Gross margin
30.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-01
Fulgent Genetics, Inc. (FLGT) Q1 2026 Earnings Call Transcript
Positive tone
Therapeutic development / FID-007
Whole genome and rare disease testing
Financial outlook and capital return
Revenue
$71.14M
▼ 3.2% YoY Gross margin
30.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-27
Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call Transcript
Positive tone
Bako (anatomic pathology) acquisition
Largest customer in-housing
Full-year and Q4 revenue results
Revenue
$83.34M*
▲ 9.3% YoY Gross margin
39.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-07
Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript
Confident tone
Laboratory Services Revenue Growth
Precision Diagnostics and Beacon Strength
Anatomic Pathology Collections Timing
Revenue
$84.07M
▲ 17.2% YoY Gross margin
42.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-01
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
Confident tone
Laboratory services revenue growth
Therapeutic development pipeline
Managed care coverage expansion
Revenue
$81.80M
▲ 15.2% YoY Gross margin
42.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-02
Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript
Confident tone
Laboratory Services Business Growth
Clinical Development Pipeline
Reproductive Health and Beacon
Revenue
$73.46M
▲ 13.9% YoY Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Call Transcript
Confident tone
Anatomic Pathology Turnaround
Therapeutic Development / Clinical Pipeline
Precision Diagnostics and Beacon
Revenue
$76.21M*
▲ 8.1% YoY Gross margin
41.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript
Confident tone
Quarterly revenue growth across lab services
Anatomic pathology turnaround improvements
VA contract for hereditary cancer and germline testing
Revenue
$71.74M
▼ 15.3% YoY Gross margin
37.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript
Confident tone
Precision Diagnostics / Reproductive Health Growth
Anatomic Pathology Turnaround
Therapeutic Development / FID-007
Revenue
$71.03M
▲ 4.7% YoY Gross margin
37.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Fulgent Genetics, Inc. (FLGT) Q1 2024 Earnings Call Transcript
Confident tone
Core revenue growth
Gross margin expansion
Anatomic pathology performance
Revenue
$64.48M
▼ 2.5% YoY Gross margin
34.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Fulgent Genetics, Inc. (FLGT) Q4 2023 Earnings Call Transcript
Positive tone
Precision Diagnostics and Carrier Screening (Beacon)
Anatomic Pathology Turnaround
Therapeutic Development / Fulgent Pharma (FID-007, FID-002)
Revenue
$70.50M*
▲ 4.1% YoY Gross margin
35.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript
Revenue
$84.69M
▼ 19.8% YoY Gross margin
47.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Fulgent Genetics, Inc. (FLGT) Q2 2023 Earnings Call Transcript
Revenue
$67.85M
▼ 45.9% YoY Gross margin
30.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Fulgent Genetics, Inc. (FLGT) Q1 2023 Earnings Call Transcript
Revenue
$66.17M
▼ 79.3% YoY Gross margin
28.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Fulgent Genetics, Inc. (FLGT) Q4 2022 Earnings Call Transcript
Revenue
$67.70M
▼ 73.1% YoY Gross margin
19.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Fulgent Genetics, Inc. (FLGT) Q3 2022 Earnings Call Transcript
Revenue
$105.66M
▼ 53.6% YoY Gross margin
43.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript
Revenue
$125.34M
▼ 18.4% YoY Gross margin
52.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-18
Fulgent Genetics, Inc. (FLGT) Q1 2022 Earnings Call Transcript
Revenue
$320.27M
▼ 10.9% YoY Gross margin
75.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Call Transcript
Revenue
$251.67M
▼ 14.7% YoY Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Fulgent Genetics, Inc. (FLGT) Q3 2021 Earnings Call Transcript
Revenue
$227.87M
▲ 124% YoY Gross margin
80.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Fulgent Genetics, Inc. (FLGT) Q2 2021 Earnings Call Transcript
Revenue
$153.62M
▲ 789.8% YoY Gross margin
76.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Fulgent Genetics, Inc. (FLGT) Q1 2021 Earnings Call Transcript
Revenue
$359.43M
▲ 4536% YoY Gross margin
79.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Fulgent Genetics, Inc. (FLGT) Q4 2020 Earnings Call Transcript
Revenue
$294.98M
▲ 3417.1% YoY Gross margin
82.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Fulgent Genetics, Inc. (FLGT) Q3 2020 Earnings Call Transcript
Revenue
$101.72M
▲ 883% YoY Gross margin
74.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Fulgent Genetics, Inc. (FLGT) Q2 2020 Earnings Call Transcript
Revenue
$17.27M
▲ 105% YoY Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
Fulgent Genetics, Inc. (FLGT) Q1 2020 Earnings Call Transcript
Revenue
$7.75M
▲ 44.4% YoY Gross margin
47.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Fulgent Genetics, Inc. (FLGT) Q4 2019 Earnings Call
Revenue
$8.39M
▲ 47.8% YoY Gross margin
56.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts
Key facts
CIK
1674930
CUSIP
359664109
13F (30d)
103 filings
89 filers
Visit website
Investor relations